<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Fusion of classical and quantum kernels enables accurate and robust two-sample tests - Health AI Hub</title>
    <meta name="description" content="This paper introduces a novel hybrid statistical testing strategy, MMD-FUSE, which fuses classical and quantum kernels to improve two-sample tests, particularly">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>Fusion of classical and quantum kernels enables accurate and robust two-sample tests</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2511.20941v1" target="_blank">2511.20941v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-11-26
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Yu Terada, Yugo Ogio, Ken Arai, Hiroyuki Tezuka, Yu Tanaka
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> quant-ph, cs.LG, stat.ME
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 1.00 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2511.20941v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2511.20941v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This paper introduces a novel hybrid statistical testing strategy, MMD-FUSE, which fuses classical and quantum kernels to improve two-sample tests, particularly for small and high-dimensional datasets. The approach enhances the Maximum Mean Discrepancy (MMD) framework by combining the unique expressive power of quantum kernels with the domain-specific biases of classical kernels. Experiments on synthetic and real-world clinical datasets demonstrate that this hybrid method achieves superior test power and remarkable robustness compared to classical counterparts.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>This methodology significantly enhances the ability to statistically compare patient groups or treatment outcomes with limited sample sizes, which is common in early-stage clinical trials or rare disease research, thereby improving drug efficacy evaluations and personalized medicine insights. It allows for more robust conclusions from smaller datasets critical in medical research.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>This paper presents MMD-FUSE, a novel hybrid statistical test that fuses classical and quantum kernels to perform robust two-sample tests. In health and medicine, this AI-driven approach can be applied to: 
1.  **Drug Efficacy/Safety Evaluation:** Accurately comparing outcomes (e.g., lab results, patient reported outcomes) between a drug treatment group and a control group in clinical trials to determine if the drug has a statistically significant effect, especially crucial for early-stage trials or rare disease studies with small cohorts. 
2.  **Biomarker Discovery and Validation:** Identifying significant differences in biomarker distributions (e.g., gene expression, protein levels) between healthy and diseased individuals, or between responders and non-responders to a therapy, aiding in diagnostic development or personalized treatment strategies. 
3.  **Clinical Decision Support:** Enhancing the statistical power and robustness of analyses used in clinical research, particularly when dealing with complex, high-dimensional patient data (e.g., multi-omics data) where traditional statistical methods might struggle due to small sample sizes. 
4.  **Real-world Evidence Analysis:** Comparing patient populations from real-world data to assess treatment effectiveness or identify risk factors, even with inherent data limitations. 
This method leverages advanced machine learning (kernel methods) and quantum computing principles to provide more effective statistical tools for data analysis in critical medical contexts.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>Addresses the critical problem of robust two-sample testing, especially when dealing with small datasets, a common challenge in scientific fields and machine learning.</li>
                    
                    <li>Proposes an enhancement to the existing MMD-FUSE framework by integrating quantum kernels, creating a novel hybrid testing strategy.</li>
                    
                    <li>The hybrid approach leverages the domain-specific inductive biases of classical kernels and the unique expressive power of quantum kernels for improved data analysis.</li>
                    
                    <li>Evaluated on diverse synthetic and real-world clinical datasets, demonstrating its practical applicability and effectiveness.</li>
                    
                    <li>MMD-FUSE with quantum kernels consistently improves test power over classical methods, particularly beneficial for small and high-dimensional data, provided appropriate hyperparameter tuning.</li>
                    
                    <li>The proposed hybrid framework exhibits exceptional robustness, adapting effectively to various data characteristics and maintaining high test power across different scenarios.</li>
                    
                    <li>Offers a versatile tool for data analysis where sample sizes are limited, promising more effective statistical tests for critical applications like drug efficacy evaluation.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>The authors enhance the existing kernel-based MMD-FUSE (Maximum Mean Discrepancy-based fusion) framework. They propose a novel hybrid testing strategy by incorporating quantum kernels alongside classical kernels. This fusion aims to combine the domain-specific inductive biases of classical kernels with the unique expressive power of quantum kernels. The method's performance was evaluated against classical counterparts using various synthetic datasets and real-world clinical datasets.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>1) With appropriate hyperparameter tuning, MMD-FUSE incorporating quantum kernels consistently demonstrates improved test power over classical kernel methods, particularly for small and high-dimensional datasets. 2) The proposed hybrid framework exhibits remarkable robustness, adapting effectively to different data characteristics and achieving high test power across diverse experimental scenarios.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>This work provides a more sensitive and reliable statistical tool for evaluating drug effectiveness, comparing patient cohorts, or assessing diagnostic markers, especially in situations where patient recruitment is challenging, or data is inherently high-dimensional (e.g., genomics, proteomics, imaging). It could accelerate the validation of new treatments by enabling robust statistical inferences from smaller, early-stage clinical trial data, thereby reducing costs and time in drug development and potentially leading to earlier patient access to effective therapies.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The performance improvement of MMD-FUSE with quantum kernels is contingent on "appropriate hyperparameter tuning," which can be a non-trivial challenge in practical applications. While not explicitly stated in the abstract, the computational overhead or specialized knowledge required for implementing quantum kernels could also be a practical limitation.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>The paper highlights the broad potential of quantum-inspired and hybrid kernel strategies for building more effective statistical tests. This suggests future research into further exploring and developing these novel kernel approaches for a wider range of data analysis problems, especially in contexts where traditional methods struggle due to limited sample sizes.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Drug Development</span>
                    
                    <span class="tag">Clinical Trials</span>
                    
                    <span class="tag">Personalized Medicine</span>
                    
                    <span class="tag">Biomarker Discovery</span>
                    
                    <span class="tag">Rare Diseases</span>
                    
                    <span class="tag">Diagnostics</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">two-sample tests</span>
                    
                    <span class="tag tag-keyword">kernel methods</span>
                    
                    <span class="tag tag-keyword">quantum kernels</span>
                    
                    <span class="tag tag-keyword">maximum mean discrepancy (MMD)</span>
                    
                    <span class="tag tag-keyword">MMD-FUSE</span>
                    
                    <span class="tag tag-keyword">small datasets</span>
                    
                    <span class="tag tag-keyword">statistical hypothesis testing</span>
                    
                    <span class="tag tag-keyword">clinical trials</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Two-sample tests have been extensively employed in various scientific fields and machine learning such as evaluation on the effectiveness of drugs and A/B testing on different marketing strategies to discriminate whether two sets of samples come from the same distribution or not. Kernel-based procedures for hypothetical testing have been proposed to efficiently disentangle high-dimensional complex structures in data to obtain accurate results in a model-free way by embedding the data into the reproducing kernel Hilbert space (RKHS). While the choice of kernels plays a crucial role for their performance, little is understood about how to choose kernel especially for small datasets. Here we aim to construct a hypothetical test which is effective even for small datasets, based on the theoretical foundation of kernel-based tests using maximum mean discrepancy, which is called MMD-FUSE. To address this, we enhance the MMD-FUSE framework by incorporating quantum kernels and propose a novel hybrid testing strategy that fuses classical and quantum kernels. This approach creates a powerful and adaptive test by combining the domain-specific inductive biases of classical kernels with the unique expressive power of quantum kernels. We evaluate our method on various synthetic and real-world clinical datasets, and our experiments reveal two key findings: 1) With appropriate hyperparameter tuning, MMD-FUSE with quantum kernels consistently improves test power over classical counterparts, especially for small and high-dimensional data. 2) The proposed hybrid framework demonstrates remarkable robustness, adapting to different data characteristics and achieving high test power across diverse scenarios. These results highlight the potential of quantum-inspired and hybrid kernel strategies to build more effective statistical tests, offering a versatile tool for data analysis where sample sizes are limited.</p>
            </section>

            
            <section class="paper-section">
                <h2>Comments</h2>
                <p>11 pages, 5 figures</p>
            </section>
            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>